NOX 0.00% 6.9¢ noxopharm limited

Ann: Pre-Clinical Breakthrough Discovery Set to Expand Pipeline, page-10

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    I agree that 'breakthrough' is a premature description if the reader thinks that it applies to pre-clinical drugs targeting pancreatic and gallbladder cancers.

    I respectfully suggest, however, that the breakthrough in this case refers to the ability to retard the Phase 2 metabolism process.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.